Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.42
-0.11 (-1.99%)
At close: Sep 26, 2025, 4:00 PM EDT
5.40
-0.02 (-0.37%)
After-hours: Sep 26, 2025, 4:09 PM EDT

Bolt Biotherapeutics Stock Forecast

BOLT's stock price has decreased by -53.79% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Bolt Biotherapeutics stock ranges from a low of $20 to a high of $75. The average analyst price target of $47.5 forecasts a 776.38% increase in the stock price over the next year.

Price Target: $47.50 (+776.38%)
Analyst Consensus: Buy
Target Low Average Median High
Price $20 $47.5 $75 $75
Change +269.00% +776.38% +1283.8% +1283.8%
* Price targets were last updated on Aug 15, 2025.

Analyst Ratings

The average analyst rating for Bolt Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Apr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy 011111
Buy 000000
Hold 522222
Sell 000000
Strong Sell 000000
Total 533333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Lake Street
Lake Street
Strong Buy
Maintains
$4$75
Strong Buy Maintains $4$75 +1,283.76% Aug 15, 2025
Lake Street
Lake Street
Strong Buy
Initiates
$80
Strong Buy Initiates $80 +1,376.01% May 20, 2025
Stifel
Stifel
Hold
Maintains
$25$20
Hold Maintains $25$20 +269.00% May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 25, 2025
Stifel
Stifel
Hold
Maintains
$30$25
Hold Maintains $30$25 +361.25% Mar 25, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
4.66M
from 7.69M
Decreased by -39.43%
Revenue Next Year
n/a
from 4.66M
EPS This Year
-24.33
from -33.06
EPS Next Year
-23.39
from -24.33
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
231.00K1.26M5.73M7.88M7.69M4.66M-
Revenue Growth
7.44%445.46%354.68%37.48%-2.36%-39.43%-
EPS
-577.72-59.40-47.16-36.60-33.06-24.33-23.39
EPS Growth
-------
Forward PE
-------
No. Analysts
-----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 6.9M n/a
Avg 4.7M n/a
Low 2.9M n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
-9.9%
-
Avg
-39.4%
-
Low
-61.8%
-

EPS Forecast

EPS 20252026202720282029
High -22.09 -13.13
Avg -24.33 -23.39
Low -25.40 -32.73

EPS Growth

EPS Growth 20252026202720282029
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.